Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term Newborns
- 1 August 1996
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 150 (8) , 802-8
- https://doi.org/10.1001/archpedi.1996.02170330028005
Abstract
Background: The American Academy of Pediatrics strategy to prevent early-onset neonatal sepsis with group B streptococcus (GBS) relies on maternal antepartum GBS cultures, while the American College of Obstetrics and Gynecology strategy does not. Objective: To evaluate the impact of the 2 strategies on the care of asymptomatic full-term newborns. Design/Setting: Self-administered survey mailed to a national random sample of US pediatricians who were members of the American Academy of Pediatrics. Participants: A total of 461 members of the American Academy of Pediatrics who routinely care for newborns. Main Outcome Measure: Self-report of diagnostic and treatment strategies for asymptomatic full-term new-borns who were born under different clinical scenarios. Maternal risk factors, antepartum maternal GBS screening status, and maternal treatment with intrapartum antibiotics were varied across the scenarios. Results: Pediatricians treating asymptomatic full-term newborns born to risk factor–negative mothers reported ordering tests (63.3% in GBS-positive cases vs 6.7% with GBS unknown; P=.001) and antibiotics (21.5% in GBS-positive cases vs 0.9% with GBS unknown; P=.001) more frequently when presented with a positive maternal GBS screening result. Maternal intrapartum treatment had little impact on pediatric practice when risk factors were absent. In risk factor–positive mothers, pediatricians reported an increase in their antibiotic usage in response to a positive maternal GBS screen (61.8% in GBS-positive cases vs 36.9% with GBS unknown; P=.001). In risk factor–positive mothers with unknown results of GBS screening, use of intrapartum antibiotics increased the number of pediatricians who reported that they would prescribe antibiotic therapy. Conclusions: Obstetrical strategies to decrease the risk of neonatal GBS sepsis increase pediatric services provided to full-term healthy newborns. This increase in services by pediatric practices is likely to be greater with the screening-based strategy recommended by the American Academy of Pediatrics. Arch Pediatr Adolesc Med. 1996;150:802-808Keywords
This publication has 11 references indexed in Scilit:
- Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysisPublished by American Medical Association (AMA) ,1993
- Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonizationAmerican Journal of Obstetrics and Gynecology, 1990
- Significance of a positive urine group B streptococcal latex agglutination test in neonatesThe Journal of Pediatrics, 1990
- Patterns of physicians' use of medical resources in ambulatory settings.American Journal of Public Health, 1987
- Group B streptococcal carriage and disease: A 6-year prospective studyThe Journal of Pediatrics, 1987
- Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum ChemoprophylaxisNew England Journal of Medicine, 1986
- An obstetric approach to the prevention of early-onset group B β-hemolytic streptococcal sepsisAmerican Journal of Obstetrics and Gynecology, 1986
- Case History Questionnaires in the Study of Doctors?? Use of ResourcesMedical Care, 1985
- Long-term sequelae of group B streptococcal meningitis in infantsThe Journal of Pediatrics, 1985
- Prospective studies of group B streptococcal infections in infantsThe Journal of Pediatrics, 1979